SCHEMBL25344783

SCHEMBL25344783

CC(C)(C)OC(=O)NCCN(CCOS(C)(=O)=O)C(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.47
IDO1 P14902 1/20 0.47
CCR6 P51684 1/20 0.44
PAX8 Q06710 1/20 0.44
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CKS1B P61024 1/20 0.42
SKP1 P63208 1/20 0.42
SKP2 Q13309 1/20 0.42
MAPT P10636 1/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
AKT1 P31749 2/20 0.39
SIGMAR1 Q99720 2/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
HDAC3 O15379 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27464982 0.91 LMNA (0.52) CCR6PAX8LMNASMN1; SMN2MAPT
SCHEMBL15716592 0.87 SYK (0.55) SYKIDO1CCR6PAX8LMNA
SCHEMBL31420836 0.87 P2RX7 (0.43) SYKIDO1CCR6PAX8LMNA
SCHEMBL31420837 0.87 P2RX7 (0.43) SYKIDO1CCR6PAX8LMNA
SCHEMBL25970217 0.85 SYK (0.53) SYKIDO1CCR6PAX8LMNA
SCHEMBL25346745 0.85 CCR6 (0.52) SYKIDO1CCR6PAX8LMNA
SCHEMBL1543294 0.84 SYK (0.48) SYKIDO1CCR6PAX8LMNA
SCHEMBL15055271 0.84 CCR6 (0.51) CCR6PAX8LMNASMN1; SMN2MAPT
SCHEMBL15841146 0.83 CCR6 (0.50) CCR6PAX8LMNAMAPTCA12
SCHEMBL8542598 0.83 L3MBTL1 (0.41) SYKCCR6PAX8LMNACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257396-A1 MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS INC (US) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257396-A1 MACROCYCLES AND THEIR USE VHL, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DLD SYK 2434/4885IDO1 3865/4885CCR6 927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.